Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.02 | 4.90 |
| PEG Ratio (TTM) | 0.21 | -1.07 |
| P/S Ratio (TTM) | 21.79 | 51.11 |
| P/B Ratio (TTM) | 0.84 | 0.94 |
| P/FCF Ratio (TTM) | N/A | 18.37 |
| Price to 5YR AVG Earnings Ratio | -2.83 | 27.93 |
| Price to 5YR AVG FCF Ratio | 7.04 | 29.55 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.37% | 1.24% |
| ROE (TTM) | 3.13% | 5.34% |
| Net Profit Margin (TTM) | 103.58% | 30.32% |
| ROIC 5YR AVG | -16.52% | 7.73% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.28% | 2,187.38% | 812.66% |
| Revenue | 148.52% | 13,955.61% | 7,883.76% |
| Net Income | 32.77% | 2,187.19% | 810.40% |
| Cash Flow | -17.90% | 194.95% | 203.83% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 1.62 |
| Quick Ratio (TTM) | N/A | 1.59 |
| D/E Ratio (TTM) | 0.68 | 0.72 |
| Interest Coverage (TTM) | 14.36 | 20.99 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.96 | 7.63 |
| LTL to 5YR AVG FCF | 1.31 | 9.24 |
| Shares Outstanding Growth 5YR AVG | 0.09% | -0.89% |